Armor Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Armor Investment Advisors's BMY Position: Q2 2023 in Review
Armor Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 12,137 shares — an estimated $841K sold.
Armor Investment Advisors first reported a position in BMY in Q4 2016 and held it in 26 quarters. The position peaked at $928K in Q2 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- Armor Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
- Armor Investment Advisors sold 12,137 Bristol-Myers Squibb shares in Q2 2023, an estimated $841K.
- Armor Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 26 quarters.
- Armor Investment Advisors's Bristol-Myers Squibb position peaked at $928K in Q2 2022.
- 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on Armor Investment Advisors's 13F filing for Q2 2023, filed 19 Jul 2023.